Inhaltspezifische Aktionen

Publikationen 2022

1.     Ahmadvand N., Carraro G., Jones M.R., Shalashova I., Noori A., Wilhelm J., Baal N., Khosravi F., Chen C., Zhang J.S., Ruppert C., Guenther A., Wasnick R.M., Bellusci S. (2022) Cell-Surface Programmed Death Ligand-1 Expression Identifies a Sub-Population of Distal Epithelial Cells Enriched in Idiopathic Pulmonary Fibrosis. CELLS-BASEL, 11(10): 0-0.

2.     Alm J., Duong Y., Wienzek-Lischka S., Cooper N., Santoso S., Sachs U.J., Kiefel V., Bein G. (2022) Anti-human platelet antigen-5b antibodies and fetal and neonatal alloimmune thrombocytopenia; incidental association or cause and effect? BRIT J HAEMATOL, 198(1): 14.

3.     Clausen F.B., Hellberg Å., Bein G., Bugert P., Schwartz D., Drnovsek T.D., Finning K., Guz K., Haimila K., Henny C., O'Brien H., Orzinska A., Sørensen K., Thorlacius S., Wikman A., Denomme G.A., Flegel W.A., Gassner C., de Haas M., Hyland C., Ji Y., Lane W.J., Nogués N., Olsson M.L., Peyrard T., van der Schoot C.E., Weinstock C., Legler T. (2022) Recommendation for validation and quality assurance of non-invasive prenatal testing for foetal blood groups and implications for IVD risk classification according to EU regulations. VOX SANG, 117(2): 157.

4.     Esmaeili B., Bayat B., Alirezaee A., Delkhah M., Mehdizadeh M.R., Pourpak Z. (2022) Human Neutrophil Antigen Genotype and Allele Frequencies in Iranian Blood Donors. J IMMUNOL RES, 2022: 4387555.

5.    Franke B., Luxembourg B., Heidinger K., Kemkes-Matthes B., Sachs U.J. (2022) Direct oral anticoagulants in patients with antiphospholipid syndrome: a retrospective study in a real-life patient cohort. BLOOD COAGUL FIBRIN, 33(3): 184.

6.     Grabowski C., Reil A., Bux J., Bayat B., Sachs U.J. (2022) Anti-human neutrophil antigen-1d specificity is frequently observed in anti-human neutrophil antigen-1b alloantisera. TRANSFUSION, 62(11): 2205.

7.     Koscielny J., Kemkes-Matthes B., Kappert G., Sucker C. (2022) Gentherapie in der Hämophilie A und B "Ante Portas": Aktuelle Entwicklungen in der ärztlichen Vergütung und Bericht Tagung Ethikrat. HAMOSTASEOLOGIE, 42(4): 274-275.

8.     Miserre L., Wienzek-Lischka S., Mann A., Cooper N., Santoso S., Ehrhardt H., Sachs U.J., Bein G. (2022) ABO Incompatibility between the Mother and Fetus Does Not Protect against Anti-Human Platelet Antigen-1a Immunization by Pregnancy. J Clin med, 11(22): 0.

9.     Müller J., Sachs U.J. (2022) Laboratory Testing: Current Aspects. HAMOSTASEOLOGIE, 42(6): 367.

10.   Müller J., Büchsel M., Timme M., App U., Miesbach W., Sachs U.J., Krause M., Scholz U. (2022) Reference Intervals in Coagulation Analysis. HAMOSTASEOLOGIE, 42(6): 381.

11.   Müller J., Miesbach W., Prüller F., Siegemund T., Scholz U., Sachs U.J., Standing Commission Labor (STAEKOLA) of the Society of Thrombosis and Haemostasis Research (GTH) (2022) An Update on Laboratory Diagnostics in Haemophilia A and B. HAMOSTASEOLOGIE, 42(4): 248.

12.   Panagiota V., Dobbelstein C., Werwitzke S., Ganser A., Cooper N., Sachs U.J., Tiede A. (2022) Long-Term Outcomes after Vaccine-Induced Thrombotic Thrombocytopenia. VIRUSES-BASEL, 14(8): 0.

13.   Sachs U.J., Kirsch-Altena A., Müller J. (2022) Markers of Hereditary Thrombophilia with Unclear Significance. HAMOSTASEOLOGIE, 42(6): 370.

14.   Sauer A., Seeliger B., Jandl K., Erfinanda L., Wilhelm J., Alexopoulos I., Baal N., Birnhuber A., David S., Welte T., Barreto G., Gaertner U., Kwapiszewska G., Seeger W., Kuebler W.M., Schaefer L., Wygrecka M., members of the CAPNETZ Study Group (2022) Circulating hyaluronic acid signature in CAP and ARDS - the role of pneumolysin in hyaluronic acid shedding. MATRIX BIOL, 114: 67.

15.   Sommer N., Noack S., Hecker A., Hackstein H., Bein G., Weissmann N., Seeger W., Mayer K., Hecker M. (2022) Correction: Sommer et al. Decreased Thymic Output Contributes to Immune Defects in Septic Patients. J. Clin. Med. 2020, 9, 2695. J Clin med, 11(15): 1-2.

16.   Waxmann Y., Arians M., Bein G., Sachs U.J., Bayat B. (2022) A Trp11Arg Substitution in the β3 Signal Peptide Prevents Expression of αIIbβ3 in Patients with Glanzmann Thrombasthenia. THROMB HAEMOSTASIS, 122(11): 1951.

17.   Wygrecka M., Wujak L., Markart P., Kosanovic D., Müller-Redetzky H.C., Witzenrath M., Henneke I., Schermuly R.T., Seeger W., Schaefer L., Kwapiszewska G., Marsh L.M., Baal N., Hackstein H., Maat S.d., Maas C. (2022) Erratum: Antihistone Properties of C1 Esterase Inhibitor Protect against Lung Injury. AM J RESP CRIT CARE, 206(9): 1184.